Gutierrez Johnny, Guimaraes Alessander O, Lewin-Koh Nicholas, Berhanu Aklile, Xu Min, Cao Yi, Kim Janice, Yan Donghong, Chang Joanna K, Dinoso Jason B, Koss Catherine A, Clemenzi-Allen Angelo, Chambers Henry F, Peck Melicent C, Baruch Amos, Rosenberger Carrie M
Genentech, Inc., South San Francisco, California.
University of California San Francisco, California.
Open Forum Infect Dis. 2019 Feb 26;6(4):ofz090. doi: 10.1093/ofid/ofz090. eCollection 2019 Apr.
(SA) bacteremia often requires a long treatment duration with antibiotics to prevent relapse due to the ability of SA to establish reservoirs of infection in sites such as heart and bone. These metastatic sites of infection cannot be serially sampled to monitor the clearance of SA infection. This study aimed to establish a link between persistence of circulating SA deoxyribonucleic acid (SA-DNA) and tissue reservoirs in patients with SA bacteremia.
A highly sensitive quantitative polymerase chain reaction was used to measure whole blood SA-DNA and plasma-derived SA cell-free DNA (SA-cfDNA) in a set of longitudinal samples from 73 patients with confirmed SA bacteremia and correlated with clinical features.
Blood SA-DNA was detected for longer than the duration of positive blood cultures. Longer duration of circulating bacterial DNA was observed in complicated SA bacteremia infections, such as endocarditis and osteoarticular infections, compared with uncomplicated bloodstream infections. In contrast, traditional blood cultures demonstrated similar time to clearance regardless of foci of infection. Plasma-derived SA-cfDNA showed concordance with blood SA-DNA levels. Baseline levels of SA-DNA were higher in patients presenting with greater clinical severity and complicated bacteremia.
Prolonged levels of circulating SA-DNA in patients with complicated tissue reservoirs after clearance of blood cultures observed in this single-center study should be validated in additional cohorts to assess the potential utility for monitoring clearance of infection in patients with SA bacteremia.
由于金黄色葡萄球菌(SA)能够在心脏和骨骼等部位建立感染灶,SA菌血症通常需要长期使用抗生素治疗以预防复发。这些转移性感染部位无法进行连续采样以监测SA感染的清除情况。本研究旨在建立SA菌血症患者循环SA脱氧核糖核酸(SA-DNA)持续存在与组织感染灶之间的联系。
采用高灵敏度定量聚合酶链反应,对73例确诊为SA菌血症患者的一组纵向样本中的全血SA-DNA和血浆来源的SA游离DNA(SA-cfDNA)进行检测,并与临床特征进行关联分析。
血液中SA-DNA的检测时间长于血培养阳性的持续时间。与非复杂性血流感染相比,在复杂性SA菌血症感染(如心内膜炎和骨关节炎感染)中观察到循环细菌DNA的持续时间更长。相比之下,传统血培养显示无论感染部位如何,清除时间相似。血浆来源的SA-cfDNA与血液SA-DNA水平一致。临床严重程度较高和菌血症复杂的患者,其SA-DNA的基线水平更高。
在这项单中心研究中观察到,血培养清除后,伴有复杂组织感染灶的患者循环SA-DNA水平持续升高,这一结果应在更多队列中进行验证,以评估其在监测SA菌血症患者感染清除方面的潜在应用价值。